NAPLEX (North American Pharmacist Licensure Examination) Practice Exam

Disable ads (and more) with a membership for a one time $4.99 payment

Ace your North American Pharmacist Licensure Examination (NAPLEX) with our comprehensive practice test. Features include interactive flashcards, multiple-choice questions, with detailed hints and explanations. Fast-track your pharmacy career today!

Practice this question and more.

Which medication is an ALK inhibitor used in the treatment of certain cancers?

Alectinib (Alecensa)
Vemurafenib (Zelboraf)
Cobimetinib (Cotellic)
Erlotinib (Tarceva)

The correct answer is: Alectinib (Alecensa)

Alectinib (Alecensa) is the correct answer. It is an ALK inhibitor used in the treatment of certain cancers, such as non-small cell lung cancer. ALK inhibitors target and inhibit the abnormal ALK gene, which plays a role in the growth and spread of cancer cells in specific types of cancer. Among the other options: - Vemurafenib (Zelboraf) is a BRAF inhibitor used for the treatment of melanoma. - Cobimetinib (Cotellic) is a MEK inhibitor used in combination with other medications for the treatment of melanoma and certain types of colorectal cancer. - Erlotinib (Tarceva) is an EGFR inhibitor used in the treatment of non-small cell lung cancer and pancreatic cancer.